Mersana Therapeutics, Inc. Public Float
Mersana Therapeutics, Inc. had Public Float of $226.28 million as of 2024-06-28, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-03-03
- 2024-06-28: Entity Public Float $226.28M.
- 2023-06-30: Entity Public Float $363.81M.
- 2022-06-30: Entity Public Float $403.31M.
- 2021-06-30: Entity Public Float $799.84M.
| Period end | Entity Public Float |
|---|---|
| 2024-06-28 | $226.28M 10-K · filed 2025-03-03 |
| 2023-06-30 | $363.81M 10-K · filed 2024-02-28 |
| 2022-06-30 | $403.31M 10-K · filed 2023-02-28 |
| 2021-06-30 | $799.84M 10-K · filed 2022-02-28 |
| 2020-06-30 | $1.15B 10-K · filed 2021-02-26 |
| 2019-06-28 | $163.61M 10-K · filed 2020-02-28 |
| 2018-06-30 | $262.61M 10-K · filed 2019-03-08 |
| 2017-06-30 | $19.15M 10-K · filed 2018-03-28 |